The activity profile of Benolea® has been extensively investigated in various studies. Benolea® develops its activity profile by means of synergy between its multiple constituents. The beneficial effects of Benolea® cannot be attributed to one single substance, but are the result of the synergistic interplay between all extract’s constituents, the multicomponent system.
In addition, Benolea® benefits from an excellent safety profile. The extract did not show any side effects and was well-tolerated in a clinical trial. Toxicological tests further confirm the excellent safety profile of the extract.

Benolea® is an olive leaf extract with clinical evidence. We continue to fund research to further support the clinical efficacy of Benolea®.

  1. Susalit E, et al., “Olive (Olea europaea) leaf extract effective in patients with stage-1 hypertension: comparison with Captopril”. Phytomedicine 18(4): 251-8 (2011).
  2. Perrinjaquet-Moccetti, et al., “Food Supplementation with an Olive (Olea europaea L.) Leaf Extract Reduces Blood Pressure in Borderline Hypertensive Monozygotic Twins,” Phytother. Res. 22(9), 1239–1242 (2008).
  3. Khayyal MT, et al., “Blood pressure lowering effect of an olive leaf extract (Olea europaea) in L-NAME induced hypertension in rats”. Arzneimittelforschung 52(11) :797-802 (2002).

Please contact us for study summaries and more information to Benolea®.